Effectiveness of the Adjuvanted Respiratory Syncytial Virus Prefusion F3 Vaccine in Preventing Major Adverse Cardiovascular Events and Severe Exacerbations of COPD and Asthma Among US Adults ≥ 60 Years of Age.
- DOI
- 10.1016/j.chest.2026.06.059
- Published
- 2026 Jul 23
- Container
- Chest
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.chest.2026.06.059,
title = {Effectiveness of the Adjuvanted Respiratory Syncytial Virus Prefusion F3 Vaccine in Preventing Major Adverse Cardiovascular Events and Severe Exacerbations of COPD and Asthma Among US Adults ≥ 60 Years of Age.},
author = {Singer D and Steffens A and La EM and Buikema AR and Horn EK and Theiss-Nyland K and Fonseca MJ and Gerber SI and Kawai A and Johnson MG and Song R and Hague S and Layton JB},
year = {2026},
journal = {Chest},
doi = {10.1016/j.chest.2026.06.059},
url = {https://doi.org/10.1016/j.chest.2026.06.059}
}RIS
TY - JOUR TI - Effectiveness of the Adjuvanted Respiratory Syncytial Virus Prefusion F3 Vaccine in Preventing Major Adverse Cardiovascular Events and Severe Exacerbations of COPD and Asthma Among US Adults ≥ 60 Years of Age. AU - Singer D AU - Steffens A AU - La EM AU - Buikema AR AU - Horn EK AU - Theiss-Nyland K AU - Fonseca MJ AU - Gerber SI AU - Kawai A AU - Johnson MG AU - Song R AU - Hague S AU - Layton JB PY - 2026 JO - Chest DO - 10.1016/j.chest.2026.06.059 UR - https://doi.org/10.1016/j.chest.2026.06.059 ER -
APA
D, S., A, S., EM, L., AR, B., EK, H., K, T., MJ, F., SI, G., A, K., MG, J., R, S., S, H., & JB, L. (2026). Effectiveness of the Adjuvanted Respiratory Syncytial Virus Prefusion F3 Vaccine in Preventing Major Adverse Cardiovascular Events and Severe Exacerbations of COPD and Asthma Among US Adults ≥ 60 Years of Age.. Chest. https://doi.org/10.1016/j.chest.2026.06.059
Source records
- pubmed · retrieved 2026-09-25T08:35:08.111Z